Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 24, Issue 1, 2007, Pages 59-64

  Bargagli, Elena ^a,b   Margollicci, Maria ^a   Perrone, Anna ^a   Luddi, Alice ^a   Perari, Maria Grazia ^a   Bianchi, Nicola ^a   Refini, Rosa Metella ^a   Grosso, Salvatore ^a   Volterrani, Luca ^a   Rottoli, Paola ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Bronchoalveolar lavage; Chitotriosidase; Sarcoidosis

Indexed keywords

CHITOTRIOSIDASE; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG INFILTRATE; LUNG LAVAGE; LUNG SARCOIDOSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; CD4-CD8 RATIO; FEMALE; HEXOSAMINIDASES; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; SARCOIDOSIS;

EID: 36549056567     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Baughman RP, Lower EE, du Bois RM: Sarcoidosis. Lancet 2003; 361: 1111-8.
2. Drent M, Costabel U: Sarcoidosis. European Respiratory Monograph 2005; 10 (32): 13.
3. Calhoun WJ, Salisbury SM, Chosy LW, Busse WW: Increased alveolar macrophages chemiluminescence and airspace cell superoxide production in active pulmonary sarcoidosis. J Lab Clin Med 1988; 112: 147-56.
4. Dai H, Guzman J, Chen B, Costabel U: Production of soluble TNF receptor and TNF alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis. Chest 2005; 127: 251-6.
5. Ziegenhagen MW, Rothe ME, Zissel G, Muller-Quernheim J: Exaggerated TNF alpha release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19: 185-90.
6. Aladesanmi OA: Sarcoidosis: an update for the primary care physicians. Med Gen Med 2004; 6: 7.
7. Grosso S, Margollicci MA, Bargagli E, et al: Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest 2004; 64: 57-62.
8. Hunninghake GW, Costabel U, Ando M, et al: ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
9. Judson MA, Baughman RP, Thompson BW, et al: Two years prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20: 204-11.
10. Sharma P, Smith I, Maguire G, et al: Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 1997; 349: 1602-3.
11. Stokes GS, Monaghan JC, Schrader AP, et al: Influence of ACE genotype on interpretation of diagnostic tests for serum ACE activity. Aust N Z J Med 1999; 29: 315-8.
12. Renkema GH, Boot RG, Au FL, et al: Chitotriosidase, a chitinase, and the 39 kDa human cartilage glycoprotein a chitin binding lectin are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 1998; 251: 504-9.
13. Wajner A, Michelin K, Burin MG, et al: Biochemical characterisation of chitotriosidase enzyme. Comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases. Clin Biochem 2004; 37: 893-7.
14. Michelakakis H, Dimitriou E, Labadaridis I: The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update. J Inherit Metab Dis 2004; 27: 705-6.
15. Artieda M, Cennaro A, Ganan A, et al: Serum chitotriosidase in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003; 23: 1645-52.
16. Altarescu G, Rudensky B, Abrahamov A, et al: Plasma chitotriosidase activity in patients with beta-thalassemia. Am J Hematol 2003; 72: 285-6.
17. Barone R, Simpore J, Malaguamera L, Pignatelli S, Musumeci S: Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin Chim Acta 2003; 331: 79-85.
18. Baughman RP, Drent M: Role of BAL in interstitial lung diseases. Clin Chest Med 2001; 22: 331-41.
19. Ziegenhagen MW, Rothe ME, Schlaak M, Muller-Quernheim J: BAL and serologial parameters reflecting the severity of sarcoidosis. Eur Respir J 2003; 21: 407-13.
20. Hunninghake GW, Gilbert S, Pueringer R, et al: Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med 1994; 149: 893-8.
21. Scadding JG: Prognosis of intrathoracic sarcoidosis in England. Br J Med 1961; 2: 1165-72.
22. Drent M, De Vries J, Lenters M, Lamers RJ, et al: Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol 2003; 13: 2462-71.
23. Oberstein A, von Aitzewitz H, Schweden F, Muller-Quernheim J: Non invasive evaluation of the inflammatory activity in sarcoidosis with HRCT. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 65-72.
24. Drent M, Jacobs JA, de Vries J, et al: Does the cellular BAL fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999; 13: 1338-44.
25. Lieberman J: Enzymes in sarcoidosis - angiotensin converting enzyme. Clin Lab Med 1989; 9: 745-55.
26. Korolenko TA, Zhanaeva SY, Falameeva Ov, et al: Chitotriosidase as a marker of macrophage stimulation. Bull Exp Biol Med 2000; 130: 948-50.
27. Aguilera B, Ghauharali-van der Vlugt K, Helmond MTJ, et al: Transglycosidase activity of chitotriosidase. J Biol Chem 2003; 42: 40911-6.
28. Elias JA, Homer RJ, Hamid Q, Lee CG: Chitinases and chitinase like proteins in T(H)2 inflammation and asthma. J Allergy Clin Immunol 2005; 116: 497-500.
29. Agostini C, Semenzato G: Cytokines in sarcoidosis. Semin Respir Infect 1998; 13: 184-96.
30. Ziegenhagen MW, Rothe ME, Schlaak M, Muller-Quernheim J: BAL and sierological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003; 21: 407-13.
31. Rottoli P, Magi B, Perari MG, et al: Cytokine profile and protome analysis in BAL of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005; 5: 1423-30.
32. Rottoli P, Bargagli E: Is bronchoalveolar lavage obsolete in the diagnosis of interstitial lung disease? Curr Opin Pulm Med 2003; 9: 418-25.
33. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PGH, Drent M: Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clinical Chemestry 2003; 49: 1510-7.
34. Muller-Quernheim J, Pfeifer S, Kienast K, Zissel G: Spontaneous IL2 release of BAL cells in sarcoidosis is a codeterminator of pognosis. Lung 1996; 174: 243-53.
35. Kantrow SP, Meyer KC, Kidd P, Raghu G: The CD4/CD8 ratio in BAL fluid is highly variable. Eur Respir J 1997; 10: 2716-21.
36. Agostini C, Trentin L, Facco M, et al: Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996; 157: 910-8.
37. Straub JP, van Kamp GJ, van Maarsseveen TC, Stam J: Biochemical parameters in BAL of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1995; 12: 51-7.
38. Sharma OP: Pulmonary sarcoidosis: management. Postgrad Med 2002; 48: 135-41.
39. Papakosta D, Kyriazis G, Gioulekas D, et al: Variations in alveolar cell populations, lymphocyte subsets and NK cells in different stages of active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 21-6.
40. Obersein A, vonZitzewitz H, Schweden F, Muller-Quernheim J: Non- invasive evaluation of the inflammatory activity in sarcoidosis with HRCT. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 65-72.
41. Mimori Y: Sarcoidosis: correlationof HRCT findings with results of pulmonary function tests and ACE assay. Kurume Med J 1998; 45: 247-56.
42. Prasse A, Pechkovsky DV, Toews GB, et al: A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006; 173: 781-92.